216 related articles for article (PubMed ID: 26337377)
1. Survival after surgical resection of distal cholangiocarcinoma: A systematic review and meta-analysis of prognostic factors.
Zhou Y; Liu S; Wu L; Wan T
Asian J Surg; 2017 Apr; 40(2):129-138. PubMed ID: 26337377
[TBL] [Abstract][Full Text] [Related]
2. The survival outcome and prognostic factors for distal cholangiocarcinoma following surgical resection: a meta-analysis for the 5-year survival.
Wellner UF; Shen Y; Keck T; Jin W; Xu Z
Surg Today; 2017 Mar; 47(3):271-279. PubMed ID: 27236779
[TBL] [Abstract][Full Text] [Related]
3. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.
Lurje G; Bednarsch J; Czigany Z; Lurje I; Schlebusch IK; Boecker J; Meister FA; Tacke F; Roderburg C; Den Dulk M; Gaisa NT; Bruners P; Neumann UP
Eur J Surg Oncol; 2019 Aug; 45(8):1468-1478. PubMed ID: 31053477
[TBL] [Abstract][Full Text] [Related]
4. Evolution of surgery for Klatskin tumor demonstrates improved outcome: a single center analysis.
Yan Y; Lu N; Tian W; Liu T
Tumori; 2014; 100(6):e250-6. PubMed ID: 25688507
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma.
Murakami Y; Uemura K; Hayashidani Y; Sudo T; Hashimoto Y; Ohge H; Sueda T
J Surg Oncol; 2007 Mar; 95(3):207-12. PubMed ID: 17278119
[TBL] [Abstract][Full Text] [Related]
6. Pancreatoduodenectomy with portal vein resection for distal cholangiocarcinoma.
Maeta T; Ebata T; Hayashi E; Kawahara T; Mizuno S; Matsumoto N; Ohta S; Nagino M;
Br J Surg; 2017 Oct; 104(11):1549-1557. PubMed ID: 28782798
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China.
Hu HJ; Mao H; Shrestha A; Tan YQ; Ma WJ; Yang Q; Wang JK; Cheng NS; Li FY
World J Gastroenterol; 2016 Feb; 22(8):2601-10. PubMed ID: 26937148
[TBL] [Abstract][Full Text] [Related]
8. Surgical management of proximal bile duct cancers.
LaFemina J; Jarnagin WR
Langenbecks Arch Surg; 2012 Aug; 397(6):869-79. PubMed ID: 22391776
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of hepatitis B virus infection in patients with intrahepatic cholangiocarcinoma.
Ahn CS; Hwang S; Lee YJ; Kim KH; Moon DB; Ha TY; Song GW; Lee SG
ANZ J Surg; 2018 Mar; 88(3):212-217. PubMed ID: 27598539
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for survival after curative resection of distal cholangiocarcinoma: perineural invasion and lymphovascular invasion.
Kim HJ; Kim CY; Hur YH; Koh YS; Kim JC; Kim HJ; Cho CK
Surg Today; 2014 Oct; 44(10):1879-86. PubMed ID: 24535697
[TBL] [Abstract][Full Text] [Related]
11. The effect of adjuvant chemotherapy in resectable cholangiocarcinoma: A meta-analysis and systematic review.
Wang ML; Ke ZY; Yin S; Liu CH; Huang Q
Hepatobiliary Pancreat Dis Int; 2019 Apr; 18(2):110-116. PubMed ID: 30470543
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in patients with middle and distal bile duct cancers.
Kwon HJ; Kim SG; Chun JM; Lee WK; Hwang YJ
World J Gastroenterol; 2014 Jun; 20(21):6658-65. PubMed ID: 24914391
[TBL] [Abstract][Full Text] [Related]
13. Confinement to the intrapancreatic bile duct is independently associated with a better prognosis in extrahepatic cholangiocarcinoma.
Ahn KS; Kang KJ; Kang YN; Kim YH; Kim TS
BMC Gastroenterol; 2016 Feb; 16():21. PubMed ID: 26911927
[TBL] [Abstract][Full Text] [Related]
14. Resection and drainage of hilar cholangiocarcinoma: an 11-year experience of a single center in mainland China.
Zheng-Rong L; Hai-Bo Y; Xin C; Chuan-Xin W; Zuo-Jin L; Bing T; Jian-Ping G; Sheng-Wei L
Am Surg; 2011 May; 77(5):627-33. PubMed ID: 21679599
[TBL] [Abstract][Full Text] [Related]
15. Recurrence after resection with curative intent for distal cholangiocarcinoma.
Komaya K; Ebata T; Shirai K; Ohira S; Morofuji N; Akutagawa A; Yamaguchi R; Nagino M;
Br J Surg; 2017 Mar; 104(4):426-433. PubMed ID: 28138968
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting survival after resection of intrahepatic cholangiocarcinoma.
Murakami S; Ajiki T; Okazaki T; Ueno K; Kido M; Matsumoto I; Fukumoto T; Ku Y
Surg Today; 2014 Oct; 44(10):1847-54. PubMed ID: 24452507
[TBL] [Abstract][Full Text] [Related]
17. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
[TBL] [Abstract][Full Text] [Related]
18. Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group.
Farges O; Fuks D; Boleslawski E; Le Treut YP; Castaing D; Laurent A; Ducerf C; Rivoire M; Bachellier P; Chiche L; Nuzzo G; Regimbeau JM
Ann Surg; 2011 Nov; 254(5):824-29; discussion 830. PubMed ID: 22042474
[TBL] [Abstract][Full Text] [Related]
19. Prognostic predictability of the new American Joint Committee on Cancer 8th staging system for distal bile duct cancer: limited usefulness compared with the 7th staging system.
Kang JS; Lee S; Son D; Han Y; Lee KB; Kim JR; Kwon W; Kim SW; Jang JY
J Hepatobiliary Pancreat Sci; 2018 Feb; 25(2):124-130. PubMed ID: 29239127
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma.
Li SQ; Liang LJ; Hua YP; Peng BG; He Q; Lu MD; Chen D
Chin Med J (Engl); 2009 Oct; 122(19):2286-91. PubMed ID: 20079127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]